Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||
19 September 2006 | Volume 145 Issue 6 | Page 472
In case 1, the patient started to notice dark urine on day 2 of treatment with telithromycin. When his wife noted continued symptoms on day 3, the patient decided to stop taking the medication. It was a week later, when the patient presented to his physician, that the laboratory tests were performed and abnormalities were noted.
With respect to case 3, I would say that the levels of acetaminophen, salicylate, and ethylene glycol were negative, which was expected based on the history given by the patient.
Potential Financial Conflicts of Interest: None disclosed.
REPLY
Severe Hepatotoxicity of Telithromycin
IN RESPONSE:
Author and Article Information
![]()
Top
Author & Article Info
From the Carolinas Medical Center, Charlotte, North Carolina.
Related articles in Annals:
| |||||||||||||||||||||||||||||||||||||||||||||||||